The store will not work correctly when cookies are disabled.
(E)-1-(1H-benzo[d]imidazol-2-yl)-3-(pyridin-2-yl)prop-2-en-1-one
ID: ALA3785531
PubChem CID: 127030655
Max Phase: Preclinical
Molecular Formula: C15H11N3O
Molecular Weight: 249.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C/c1ccccn1)c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C15H11N3O/c19-14(9-8-11-5-3-4-10-16-11)15-17-12-6-1-2-7-13(12)18-15/h1-10H,(H,17,18)/b9-8+
Standard InChI Key: KLRYSKMQNHKBRZ-CMDGGOBGSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7008 -0.9930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3215 1.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0552 2.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5551 2.6994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2857 4.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5165 5.2972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0166 5.2749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2860 3.9648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
8 10 1 0
10 11 1 0
10 12 2 0
11 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.27 | Molecular Weight (Monoisotopic): 249.0902 | AlogP: 2.85 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.64 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.06 | CX Basic pKa: 4.52 | CX LogP: 2.57 | CX LogD: 2.56 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.57 | Np Likeness Score: -1.03 |
References
1. Wu LT, Jiang Z, Shen JJ, Yi H, Zhan YC, Sha MQ, Wang Z, Xue ST, Li ZR.. (2016) Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents., 114 [PMID:27017265] [10.1016/j.ejmech.2016.03.029] |